GGrantIndex
Sort

10,766 grants matching checkpoint inhibitor

Development of new treatments for rare CNS tumors

$87,286
Marta Penas-Prado · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

DNA Damage Response Markers in Barrett's Esophagus

$87,250
Gregory H. Enders · Fox Chase Cancer Center · R03 · FY2010 · CA

DNA Damage Response Markers in Barrett's Esophagus

$87,209
Gregory H. Enders · Fox Chase Cancer Center · R03 · FY2009 · CA

Gastrointestinal Cancer Research Program (GI) (Project-005)

$87,030
Jordan D Berlin · Vanderbilt University Medical Center · P30 · FY2017 · CA

Gastrointestinal Cancer Research Program (GI) (Project-005)

$87,030
Jordan D Berlin · Vanderbilt University Medical Center · P30 · FY2018 · CA

Tumor Intrinsic Regulation of Immune Evasion Pathways in Breast Cancer

$86,968
Sheera Rosenbaum · University Of Colorado Denver · K00 · FY2021 · CA

G2 CHECKPOINT INTEGRITY IN P53 DEPLETED CELLS

$86,733
Fred Hutchinson Cancer Research Center · K08 · FY2000 · CA

Modulation of the tumor microenvironment with probiotic therapies

$86,602
Tal Danino · Columbia Univ New York Morningside · R01 · FY2023 · CA

TGX-1214 - Combination Strategy for the Treatment of Advanced Pancreatic Cancer

$86,583
Gerardo Guillermo Mackenzie · University Of California At Davis · R01 · FY2025 · CA

Molecular Characterization of Autoreactive B Cells in Immune Checkpoint Inhibitor-Induced Autoimmune Sicca

$86,500
Rachel H Bonami · Vanderbilt University Medical Center · R03 · FY2021 · AI

Molecular Characterization of Autoreactive B Cells in Immune Checkpoint Inhibitor-Induced Autoimmune Sicca

$86,500
Rachel H Bonami · Vanderbilt University Medical Center · R03 · FY2022 · AI

Regulation of Genomic Instability in Early Breast Cancer

$86,217
Thea D Tlsty · University Of California, San Francisco · R01 · FY2007 · CA

Project 1: Targeting immunotherapy-induced resistance with DC vaccination and PD-1/CSF-1R inhibition

$86,121
Robert M Prins · University Of California Los Angeles · P50 · FY2024 · CA

Hypovitaminosis D promotes MED12-associated genomic instability in uterine fibroids

$86,045
Thomas G Boyer · University Of Texas Hlth Science Center · R01 · FY2022 · HD

Development of Preventive Strategies and Therapy for HIV Infection

$85,899
Robert Yarchoan · Division Of Clinical Sciences - Nci · ZIA · FY2023 · CA

Investigating Immune Responses to Neoantigen Cancer Vaccines using In Vivo Functionalized Lineage

$85,860
Camila Robles-Oteiza · Dana-Farber Cancer Inst · K00 · FY2022 · CA

Development of Immunotherapy for Medullary Thyroid Cancer

$85,856
Ravi Madan · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Modulation of the tumor microenvironment with probiotic therapies

$85,800
Tal Danino · Columbia Univ New York Morningside · R01 · FY2022 · CA

An individualized network medicine infrastructure for precision cardio-oncology

$85,785
Feixiong Cheng · Northeastern University · K99 · FY2017 · HL

Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer

$85,665
Barbara Burtness · Yale University · P50 · FY2022 · DE

Immunology and Cancer Immunotherapy

$85,391
Mary J Turk · Dartmouth College · P30 · FY2025 · CA

Developmental Therapeutics

$85,361
John James Letterio · Case Western Reserve University · P30 · FY2025 · CA

Adrenergic signaling inhibition to enhance the immunogenicity of the ovarian tumor microenvironment prior to PD-1 checkpoint therapy

$85,329
Guillermo N Armaiz-Pena · Ponce School Of Medicine · R21 · FY2021 · CA

Regulation of the Anaphase-Promoting Complex by the Spindle Checkpoint

$85,000
Hongtao Yu · Ut Southwestern Medical Center · R01 · FY2009 · GM

Radiobiology and Imaging Program

$84,880
Amit Maity · University Of Pennsylvania · P30 · FY2022 · CA